196 related articles for article (PubMed ID: 35272744)
1. Transmission dynamics and epidemiological characteristics of SARS-CoV-2 Delta variant infections in Guangdong, China, May to June 2021.
Kang M; Xin H; Yuan J; Ali ST; Liang Z; Zhang J; Hu T; Lau EH; Zhang Y; Zhang M; Cowling BJ; Li Y; Wu P
Euro Surveill; 2022 Mar; 27(10):. PubMed ID: 35272744
[TBL] [Abstract][Full Text] [Related]
2. Contact tracing period and epidemiological characteristics of an outbreak of the SARS-CoV-2 Delta variant in Guangzhou.
Ma X; Wu K; Li Y; Li S; Cao L; Xie H; Zheng J; Zhou R; Yuan Z; Huang Z; Yuan J; Wu X
Int J Infect Dis; 2022 Apr; 117():18-23. PubMed ID: 35101637
[TBL] [Abstract][Full Text] [Related]
3. Transmission Dynamics of the Delta Variant of SARS-CoV-2 Infections in South Korea.
Hwang H; Lim JS; Song SA; Achangwa C; Sim W; Kim G; Ryu S
J Infect Dis; 2022 Mar; 225(5):793-799. PubMed ID: 34865022
[TBL] [Abstract][Full Text] [Related]
4. [Epidemiological characteristics of local outbreak of COVID-19 caused by SARS-CoV-2 Delta variant in Liwan district, Guangzhou].
Li WY; Du ZC; Wang Y; Lin X; Lu L; Fang Q; Zhang WF; Cai MW; Xu L; Hao YT
Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1763-1768. PubMed ID: 34814609
[No Abstract] [Full Text] [Related]
5. Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants.
Trobajo-Sanmartín C; Martínez-Baz I; Miqueleiz A; Fernández-Huerta M; Burgui C; Casado I; Baigorría F; Navascués A; Castilla J; Ezpeleta C
Microbiol Spectr; 2022 Apr; 10(2):e0000822. PubMed ID: 35412379
[TBL] [Abstract][Full Text] [Related]
6. Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study.
Jing QL; Liu MJ; Zhang ZB; Fang LQ; Yuan J; Zhang AR; Dean NE; Luo L; Ma MM; Longini I; Kenah E; Lu Y; Ma Y; Jalali N; Yang ZC; Yang Y
Lancet Infect Dis; 2020 Oct; 20(10):1141-1150. PubMed ID: 32562601
[TBL] [Abstract][Full Text] [Related]
7. Impact of Delta Variant and Vaccination on SARS-CoV-2 Secondary Attack Rate Among Household Close Contacts.
Ng OT; Koh V; Chiew CJ; Marimuthu K; Thevasagayam NM; Mak TM; Chua JK; Ong SSH; Lim YK; Ferdous Z; Johari AKB; Chen MI; Maurer-Stroh S; Cui L; Lin RTP; Tan KB; Cook AR; Leo PY; Lee PVJ
Lancet Reg Health West Pac; 2021 Dec; 17():100299. PubMed ID: 34746899
[TBL] [Abstract][Full Text] [Related]
8. Transmission and containment of the SARS-CoV-2 Delta variant of concern in Guangzhou, China: A population-based study.
Li L; Han ZG; Qin PZ; Liu WH; Yang Z; Chen ZQ; Li K; Xie CJ; Ma Y; Wang H; Huang Y; Fan SJ; Yan ZL; Ou CQ; Luo L
PLoS Negl Trop Dis; 2022 Jan; 16(1):e0010048. PubMed ID: 34986169
[TBL] [Abstract][Full Text] [Related]
9. Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination and Pediatric Age on Delta Variant Household Transmission.
Ng OT; Koh V; Chiew CJ; Marimuthu K; Thevasagayam NM; Mak TM; Chua JK; Ong SSH; Lim YK; Ferdous Z; Johari AKB; Cui L; Lin RTP; Tan KB; Cook AR; Leo YS; Lee VJM
Clin Infect Dis; 2022 Aug; 75(1):e35-e43. PubMed ID: 35323887
[TBL] [Abstract][Full Text] [Related]
10. Transmission dynamics of SARS-CoV-2 Omicron variant infections in Hangzhou, Zhejiang, China, January-February 2022.
Xin H; Wang Z; Feng S; Sun Z; Yu L; Cowling BJ; Kong Q; Wu P
Int J Infect Dis; 2023 Jan; 126():132-135. PubMed ID: 36511336
[TBL] [Abstract][Full Text] [Related]
11. The Association Between Clinical Severity and Incubation Period of SARS-CoV-2 Delta Variants: Retrospective Observational Study.
Wang K; Luan Z; Guo Z; Ran J; Tian M; Zhao S
JMIR Public Health Surveill; 2022 Nov; 8(11):e40751. PubMed ID: 36346940
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 Delta Variant in Jingmen City, Hubei Province, China, 2021: Children Susceptible and Vaccination Breakthrough Infection.
Li D; Li AE; Li ZQ; Bao Y; Liu T; Qin XR; Yu XJ
Front Microbiol; 2022; 13():856757. PubMed ID: 35495649
[TBL] [Abstract][Full Text] [Related]
13. Association of SARS-CoV-2 viral load distributions with individual demographics and suspected variant type: results from the Liverpool community testing pilot, England, 6 November 2020 to 8 September 2021.
Hughes DM; Cheyne CP; Ashton M; Coffey E; Crozier A; Semple MG; Buchan I; García-Fiñana M
Euro Surveill; 2023 Jan; 28(4):. PubMed ID: 36700865
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of Inactivated COVID-19 Vaccines Against Illness Caused by the B.1.617.2 (Delta) Variant During an Outbreak in Guangdong, China : A Cohort Study.
Kang M; Yi Y; Li Y; Sun L; Deng A; Hu T; Zhang J; Liu J; Cheng M; Xie S; Luo M; Jiang J; Jiang Y; Tang S; He J
Ann Intern Med; 2022 Apr; 175(4):533-540. PubMed ID: 35099990
[TBL] [Abstract][Full Text] [Related]
15. [Progress in research of epidemiologic feature and control of SARS-CoV-2 Delta variant].
Du M; Liu M; Liu J
Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1774-1779. PubMed ID: 34814611
[TBL] [Abstract][Full Text] [Related]
16. Transmission of SARS-CoV-2 infection and risk factors in a cohort of close contacts.
Martínez-Baz I; Trobajo-Sanmartín C; Burgui C; Casado I; Castilla J
Postgrad Med; 2022 Mar; 134(2):230-238. PubMed ID: 35102793
[TBL] [Abstract][Full Text] [Related]
17. [Epidemiological characteristics of COVID-19 caused by 2019-nCoV Delta variant in Shangyu district, Shaoxing of Zhejiang province].
Wu YY; Wang Z; Chai CL; He F; Ling F; Pan J; Li FD; Cheng W; Liu K; Zhang Y; Zhang GM; Yu M
Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Jun; 43(6):846-851. PubMed ID: 35725340
[No Abstract] [Full Text] [Related]
18. SARS-CoV-2 RNA load and detection rate in exhaled breath condensate collected from COVID-19 patients infected with Delta variant.
Sawano M; Takeshita K; Ohno H; Oka H
J Breath Res; 2022 Jun; 16(3):. PubMed ID: 35580553
[TBL] [Abstract][Full Text] [Related]
19. Dynamic characteristics of a COVID-19 outbreak in Nanjing, Jiangsu province, China.
Wang J; Ma T; Ding S; Xu K; Zhang M; Zhang Z; Dai Q; Tao S; Wang H; Cheng X; He M; Du X; Feng Z; Yang H; Wang R; Xie C; Xu Y; Liu L; Chen X; Li C; Wu W; Ye S; Yang S; Fan H; Zhou N; Ding J
Front Public Health; 2022; 10():933075. PubMed ID: 36483256
[TBL] [Abstract][Full Text] [Related]
20. Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance - COVID-NET, 14 States, January-August 2021.
Taylor CA; Patel K; Pham H; Whitaker M; Anglin O; Kambhampati AK; Milucky J; Chai SJ; Kirley PD; Alden NB; Armistead I; Meek J; Yousey-Hindes K; Anderson EJ; Openo KP; Teno K; Weigel A; Monroe ML; Ryan PA; Henderson J; Nunez VT; Bye E; Lynfield R; Poblete M; Smelser C; Barney GR; Spina NL; Bennett NM; Popham K; Billing LM; Shiltz E; Abdullah N; Sutton M; Schaffner W; Talbot HK; Ortega J; Price A; Garg S; Havers FP;
MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(43):1513-1519. PubMed ID: 34710076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
